Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02500797
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:31.441198+00:00
Published At
2020-06-16T00:00:00+00:00
Record Updated At
2023-10-17
Results Posted At
2020-06-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Locally Advanced Bone Sarcoma", "Locally Advanced Dedifferentiated Liposarcoma", "Locally Advanced Gastrointestinal Stromal Tumor", "Locally Advanced Soft Tissue Sarcoma", "Metastatic Bone Sarcoma", "Metastatic Liposarcoma", "Metastatic Soft Tissue Sarcoma", "Metastatic Undifferentiated Pleomorphic Sarcoma", "Metastatic Unresectable Sarcoma", "Pleomorphic Liposarcoma", "Stage III Bone Sarcoma AJCC v7", "Stage III Soft Tissue Sarcoma AJCC v7", "Stage IV Bone Sarcoma AJCC v7", "Stage IV Soft Tissue Sarcoma AJCC v7", "Stage IVA Bone Sarcoma AJCC v7", "Stage IVB Bone Sarcoma AJCC v7", "Unresectable Bone Sarcoma", "Unresectable Dedifferentiated Liposarcoma", "Unresectable Liposarcoma", "Unresectable Malignant Gastrointestinal Stromal Tumor", "Unresectable Soft Tissue Sarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-10-17"
protocolSection.identificationModule.nctId
"NCT02500797"
protocolSection.identificationModule.officialTitle
"Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-06-16"

Study condition terms

  • Locally Advanced Bone Sarcoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Dedifferentiated Liposarcoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Gastrointestinal Stromal Tumor (protocolSection.conditionsModule.conditions)
  • Locally Advanced Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Metastatic Bone Sarcoma (protocolSection.conditionsModule.conditions)
  • Metastatic Liposarcoma (protocolSection.conditionsModule.conditions)
  • Metastatic Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Metastatic Undifferentiated Pleomorphic Sarcoma (protocolSection.conditionsModule.conditions)
  • Metastatic Unresectable Sarcoma (protocolSection.conditionsModule.conditions)
  • Pleomorphic Liposarcoma (protocolSection.conditionsModule.conditions)
  • Stage III Bone Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Soft Tissue Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Bone Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Soft Tissue Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Bone Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Bone Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Unresectable Bone Sarcoma (protocolSection.conditionsModule.conditions)
  • Unresectable Dedifferentiated Liposarcoma (protocolSection.conditionsModule.conditions)
  • Unresectable Liposarcoma (protocolSection.conditionsModule.conditions)
  • Unresectable Malignant Gastrointestinal Stromal Tumor (protocolSection.conditionsModule.conditions)
  • Unresectable Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.